Corcept Therapeutics Inc
CORT· Nasdaq
Released Aug 9, 2018, after the close
10-Q filed Aug 9, 2018, 40 days after period end · 0001564590-18-021092
| Metric | Q2 2018 | Q2 2017 | Q2 2016 | Q2 2015 |
|---|---|---|---|---|
| Revenue | $62.31M | $35.56M | $19.72M | $11.96M |
| Net Income | $18.20M | $12.65M | $977.00K | -$1.94M |
| EPS Diluted |
Corcept Therapeutics Inc · CIK 1088856 · Engraved from SEC EDGAR
| $0.14 |
| $0.10 |
| $0.01 |
| -$0.02 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.